| CZMVX | VIVIX | CZMVX / VIVIX | |
| Total Expense Ratio | 0.69 | 0.04 | 1,725% |
| Annual Report Gross Expense Ratio | 0.70 | 0.04 | 1,750% |
| Fund Existence | 9 years | 28 years | - |
| Gain YTD | 5.391 | 5.999 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.83B | 218B | 3% |
| Annual Yield % from dividends | 1.26 | 1.96 | 65% |
| Returns for 1 year | 0.46 | 15.08 | 3% |
| Returns for 3 years | 11.40 | 41.04 | 28% |
| Returns for 5 years | 11.94 | 66.28 | 18% |
| Returns for 10 years | N/A | 167.19 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TRZQX | 40.51 | 0.24 | +0.60% |
| T. Rowe Price Equity Income Z | |||
| GSBIX | 27.94 | 0.05 | +0.18% |
| Goldman Sachs Income Builder Instl | |||
| BUIOX | 16.97 | -0.09 | -0.53% |
| Buffalo Early Stage Growth Instl | |||
| RYTFX | 7.65 | -0.05 | -0.65% |
| Royce Small-Cap Total Return Svc | |||
| WOOPX | 17.42 | -0.15 | -0.85% |
| JPMorgan SMID Cap Equity I | |||